We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

Back to rankings

185 hedge funds and large institutions have $1B invested in AMAG Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 75 increasing their positions, 43 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 43

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

47% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 30

8% more funds holding

Funds holding: 172 → 185 (+13)

24% less capital invested

Capital invested by funds: $1.32B → $1B (-$311M)

99% less call options, than puts

Call options by funds: $1.82M | Put options by funds: $175M

Holders
185
Holders Change
+13
Holders Change %
+7.56%
% of All Funds
4.93%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
44
Increased
75
Reduced
43
Closed
30
Calls
$1.82M
Puts
$175M
Net Calls
-$173M
Net Calls Change
-$172M

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$36.3M
2
SIM
Stelliam Investment Management
New York
+$18.6M
3
CCM
Camber Capital Management
Massachusetts
+$14.2M
4
FPC
Falcon Point Capital
California
+$9.04M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.94M

Top Sellers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$31.8M
2
Millennium Management
Millennium Management
New York
-$29.3M
3
PI
Putnam Investments
Massachusetts
-$26.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$23.7M
5
PC
PointState Capital
New York
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$3.39M +$2.32M +97,639 +206%
QI
52
QS Investors
New York
$3.29M – – –
BIM
53
BlackRock Investment Management
Delaware
$3.19M +$883K +37,222 +38%
Susquehanna International Group
54
Susquehanna International Group
Pennsylvania
$2.8M -$2M -84,444 -41%
Bank of America
55
Bank of America
North Carolina
$2.79M +$122K +5,154 +5%
TCIM
56
TIAA CREF Investment Management
New York
$2.71M -$12.8K -539 -0.5%
Wells Fargo
57
Wells Fargo
California
$2.69M -$249K -10,503 -8%
Millennium Management
58
Millennium Management
New York
$2.48M -$29.3M -1,234,273 -92%
GC
59
Guggenheim Capital
Illinois
$2.36M -$532K -22,417 -18%
LSV Asset Management
60
LSV Asset Management
Illinois
$2.33M +$138K +5,800 +6%
California Public Employees Retirement System
61
California Public Employees Retirement System
California
$2.3M -$140K -5,900 -6%
AIS
62
AlphaOne Investment Services
Pennsylvania
$2.15M +$119K +5,007 +6%
SI
63
Sprott Inc
Ontario, Canada
$2.11M +$2.14M +90,000 New
CEI
64
Clark Estates Inc
New York
$2.06M +$2.09M +88,100 New
BA
65
BlackRock Advisors
Delaware
$2.04M +$874K +36,845 +73%
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$1.71M -$1.24M -52,303 -42%
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$1.71M +$217K +9,158 +14%
Bank of Montreal
68
Bank of Montreal
Ontario, Canada
$1.6M -$171K -7,213 -10%
State of New Jersey Common Pension Fund D
69
State of New Jersey Common Pension Fund D
New Jersey
$1.55M – – –
EC
70
Engaged Capital
California
$1.54M +$107K +4,491 +7%
New York State Common Retirement Fund
71
New York State Common Retirement Fund
New York
$1.49M – – –
DCM
72
Dupont Capital Management
Delaware
$1.46M – – –
SFM
73
Systematic Financial Management
New Jersey
$1.45M +$4.39K +185 +0.3%
AQR Capital Management
74
AQR Capital Management
Connecticut
$1.44M +$278K +11,706 +23%
AA
75
ALPS Advisors
Colorado
$1.35M +$50.9K +2,145 +4%
1 2
3
4 5

AMAG Hedge Fund Activity: Q1 2016 in Review

185 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q1 2016, worth a combined $1B — down 24% from $1.32B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new AMAG positions and 30 closed out — a net gain of 14 holders — while 75 added to existing stakes and 43 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $36.3M. The largest seller was Westfield Capital Management, cutting an estimated $31.8M.

  • 185 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q1 2016, up from 172 in Q4 2015.
  • Funds reported $1B of AMAG Pharmaceuticals stock for Q1 2016, down 24% quarter-over-quarter.
  • 44 funds opened new AMAG Pharmaceuticals positions in Q1 2016 and 30 closed out, a net change of +14 holders.
  • The largest AMAG Pharmaceuticals buyer in Q1 2016 was BlackRock Fund Advisors, an estimated $36.3M added.
  • The largest AMAG Pharmaceuticals seller in Q1 2016 was Westfield Capital Management, an estimated $31.8M sold.

Based on aggregated 13F filings for Q1 2016.